Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaElias Jabbour, Josep‐María Ribera, Hagop M. Kantarjian et al.|JAMA|2024Cited by 119
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trialMeletios Α. Dimopoulos, Shaji Kumar, Hang Quach et al.|Blood Cancer Journal|2022Cited by 21